share_log

IO Biotech Analyst Ratings

Benzinga ·  Sep 28, 2023 07:16
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/28/2023 681.25% Piper Sandler → $10 Initiates Coverage On → Overweight
09/13/2023 525% HC Wainwright & Co. → $8 Reiterates Buy → Buy
08/15/2023 446.87% Morgan Stanley $11 → $7 Maintains Overweight
08/11/2023 525% HC Wainwright & Co. $11 → $8 Reiterates Buy → Buy
03/15/2023 681.25% HC Wainwright & Co. → $10 Reiterates → Buy
01/24/2023 759.37% Morgan Stanley $15 → $11 Maintains Overweight
11/21/2022 681.25% HC Wainwright & Co. → $10 Initiates Coverage On → Buy
11/30/2021 1540.62% Morgan Stanley → $21 Initiates Coverage On → Overweight
11/30/2021 Cowen & Co. Initiates Coverage On → Outperform
11/30/2021 1462.5% Jefferies → $20 Initiates Coverage On → Buy

What is the target price for IO Biotech (IOBT)?

There is no price target for IO Biotech

What is the most recent analyst rating for IO Biotech (IOBT)?

There is no analyst for IO Biotech

When is the next analyst rating going to be posted or updated for IO Biotech (IOBT)?

There is no next analyst rating for IO Biotech

Is the Analyst Rating IO Biotech (IOBT) correct?

There is no next analyst rating for IO Biotech

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment